IP Library › Granted Patent US 8,481,734

Granted Patent B2

US 8,481,734 · App. 12/351,891 · Granted Jul 9, 2013

Pyrazine derivatives and uses thereof, including in medical imaging and visualization applications

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 8,481,734
App. No.: 12/351,891
Granted: Jul 9, 2013
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

Disclosed herein are pyrazine derivatives of Formula I: Formula I; wherein each of X 1 and X 2 is independently —CONR 7 R 9 ; and each of Y 1 and Y 2 is independently —NR 48 R 49 ; and methods of using the same. The disclosed pyrazine derivatives include those having urea, amide, sulfonamide, thiourea, and/or carbamate substituents. Among the various aspects of the present invention are pyrazine derivatives that may be detected in vivo and used in a number of medical procedures (e.g., renal function monitoring). Without being bound by a particular theory, the pyrazine derivatives described herein may be designed to be hydrophilic, thus allowing for rapid renal clearance for continuous monitoring of renal function.

Claims (47)

1. A compound of the Formula I:

Formula I; wherein

each of X 1 and X 2 is independently —CONR 7 R 9 ;

each of Y 1 and Y 2 is independently —NR 48 R 49 ;

each R 7 is independently —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c NR 10 CONR 11 (CH 2 ) d (CH 2 CH 2 O) e R 20 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c NR 12 CSNR 13 (CH 2 ) d (CH 2 CH 2 O) e R 21 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c CONR 14 (CH 2 ) d (CH 2 CH 2 O) e R 22 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c NR 15 SO 2 (CH 2 ) d (CH 2 CH 2 O) e R 23 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c SO 2 NR 16 (CH 2 ) d (CH 2 CH 2 O) e R 24 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c NR 17 CO(CH 2 ) d (CH 2 CH 2 O) e R 25 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c NR 18 CO 2 (CH 2 ) d (CH 2 CH 2 O) e R 26 , or —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c OC(O)NR 19 CO 2 (CH 2 ) d (CH 2 CH 2 O) e R 27 ;

each R 48 is independently —(CH 2 ) c OR 68 , —CH 2 (CHOH) c R 69 , —CH 2 (CHOH) c CO 2 H, —(CHCO 2 H) c CO 2 H, —(CH 2 ) c NR 70 R 71 , —CH[(CH 2 ) f NH 2 ] c CO 2 H, —CH[(CH 2 ) f NH 2 ] c CH 2 OH, —CH 2 (CHNH 2 ) c CH 2 NR 72 R 73 , —(CH 2 CH 2 O) e R 74 , —(CH 2 ) t CO(CH 2 CH 2 O) e R 75 , —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k NR 58 C(O)NR 59 (CH 2 ) l (CH 2 CH 2 O) o R 76 , —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k NR 60 C(S)NR 61 (CH 2 ) l (CH 2 CH 2 O) o R 77 , —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k C(O)NR 62 (CH 2 ) l (CH 2 CH 2 O) o R 78 , —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k S(O) 2 NR 63 (CH 2 ) l (CH 2 CH 2 O) o R 79 , —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k NR 64 S(O) 2 (CH 2 ) l (CH 2 CH 2 O) o R 80 , —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k NR 65 C(O)(CH 2 ) l (CH 2 CH 2 O) o R 81 , —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k NR 66 C(O)O(CH 2 ) l (CH 2 CH 2 O) o R 82 , or —(CH 2 ) u (CH 2 CH 2 O) j (CH 2 ) k OC(O)NR 67 (CH 2 ) l (CH 2 CH 2 O) o R 83 , —(CH 2 ) a SO 3 H, —(CH 2 ) a SO 3 − , —(CH 2 ) a OSO 3 H, —(CH 2 ) a OSO 3 − , —(CH 2 ) a NHSO 3 H, —(CH 2 ) a NHSO 3 − , —(CH 2 ) a PO 3 H 2 , —(CH 2 ) a PO 3 H − , —(CH 2 ) a PO 3 ═ , —(CH 2 ) a OPO 3 H 2 , —(CH 2 ) a OPO 3 H − , or —(CH 2 ) a OPO 3 ;

each R 49 is independently —H, —(CH 2 ) c OR 68 , —CH 2 (CHOH) c R 69 , —CH 2 (CHOH) c CO 2 H, —(CHCO 2 H) c CO 2 H, —(CH 2 ) c NR 70 R 71 , —CH[(CH 2 ) f NH 2 ] c CO 2 H, —CH[(CH 2 ) f NH 2 ] c CH 2 OH, —CH 2 (CHNH 2 ) c CH 2 NR 72 R 73 , —(CH 2 CH 2 O) e R 74 , —(CH 2 ) c CO(CH 2 CH 2 O) e R 75 , —(CH 2 ) i (CH 2 CH 2 O) j (CH 2 ) k NR 58 C(O)NR 59 (CH 2 ) l (CH 2 CH 2 O) o R 76 , —(CH 2 ) i (CH 2 CH 2 O) j (CH 2 ) k NR 60 C(S)NR 61 (CH 2 ) l (CH 2 CH 2 O) o R 77 , —(CH 2 ) i (CH 2 CH 2 O) j (CH 2 ) k C(O)NR 62 (CH 2 ) l (CH 2 CH 2 O) o R 78 , —(CH 2 ) i (CH 2 CH 2 O) j (CH 2 ) k S(O) 2 NR 63 (CH 2 ) l (CH 2 CH 2 O) o R 79 , —(CH 2 ) i (CH 2 CH 2 O) j (CH 2 ) k NR 64 S(O) 2 (CH 2 ) l (CH 2 CH 2 O) o R 80 , —(CH 2 ) i (CH 2 CH 2 O) j (CH 2 ) k NR 65 C(O)(CH 2 ) l (CH 2 CH 2 O) o R 81 , —(CH 2 ) i (CH 2 CH 2 O) j (CH 2 ) k NR 66 C(O)O(CH 2 ) l (CH 2 CH 2 O) o R 82 , —(CH 2 ) i (CH 2 CH 2 O) j (CH 2 ) k OC(O)NR 67 (CH 2 ) l (CH 2 CH 2 O) o R 83 , —(CH 2 ) a SO 3 H, —(CH 2 ) a SO 3 − , —(CH 2 ) a OSO 3 H, —(CH 2 ) a OSO 3 − , —(CH 2 ) a NHSO 3 H, —(CH 2 ) a NHSO 3 − , —(CH 2 ) a PO 3 H 2 , —(CH 2 ) a PO 3 H − , —(CH 2 ) a PO 3 ═ , —(CH 2 ) a OPO 3 H 2 , —(CH 2 ) a OPO 3 H − , or —(CH 2 ) a OPO 3 ;

each of R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , and R 19 is independently —H or —CH 3 ;

each of R 20 , R 21 , R 22 , R 23 , R 24 , R 25 , R 26 , and R 27 is independently —H, —CH 3 , —(CH 2 ) f NR 28 C(O)NR 29 (CH 2 ) g (CH 2 CH 2 O) h R 38 , —(CH 2 ) f NR 30 CSNR 31 (CH 2 ) g (CH 2 CH 2 O) h R 39 , —(CH 2 ) f C(O)NR 32 (CH 2 ) g (CH 2 CH 2 O) h R 40 , —(CH 2 ) f S(O) 2 NR 33 (CH 2 ) g (CH 2 CH 2 O) h R 41 , —(CH 2 ) f NR 34 S(O) 2 (CH 2 ) g (CH 2 CH 2 O) h R 42 , —(CH 2 ) f NR 35 C(O)(CH 2 ) g (CH 2 CH 2 O) h R 43 , —(CH 2 ) f NR 36 C(O)O(CH 2 ) g (CH 2 CH 2 O) h R 44 , —(CH 2 ) f OC(O)NR 37 (CH 2 ) g (CH 2 CH 2 O) h R 45 , —CO(AA), or —CONH(PS);

each of R 28 , R 29 , R 30 , R 31 , R 32 , R 33 , R 34 , R 35 , R 36 , and R 37 is independently —H or —CH 3 ;

each of R 38 , R 39 , R 40 , R 41 , R 42 , R 43 , R 44 , to and R 45 is independently —H, —CH 3 , —CO(AA) or —CONH(PS);

each of R 58 , R 59 , R 60 , R 61 , R 62 , R 63 , R 64 , R 65 , R 66 , and R 67 is independently, —H or —CH 3 ;

each of R 68 , R 69 , R 70 , R 71 , R 72 , R 73 , R 74 , R 75 , R 76 , R 77 , R 78 , R 79 , and R 80 is independently —H, —CH 3 , —(CH 2 ) p S(O) 2 NR 84 (CH 2 ) q (CH 2 CH 2 O) s R 81 , —(CH 2 ) p NR 85 S(O) 2 (CH 2 ) q (CH 2 CH 2 O) s R 83 , —(CH 2 ) p NR 86 C(O)(CH 2 ) q (CH 2 CH 2 O) s R 85 , —(CH 2 ) p NR 86 C(O)O(CH 2 ) q (CH 2 CH 2 O) s R 87 , or —(CH 2 ) p OC(O)NR 88 (CH 2 ) q (CH 2 CH 2 O) s R 89 ;

each of R 81 , R 82 , R 83 , R 84 , R 85 , R 86 , R 87 , R 88 , and R 89 is independently —H or —CH 3 ;

each (AA) is independently a polypeptide chain that includes one or more natural or unnatural α-amino acids linked together by peptide bonds;

each (PS) is independently a sulfated or non-sulfated polysaccharide chain comprising one or more monosaccharide units connected by glycosidic linkages;

each of ‘t’ and ‘u’ is independently 1, 2, 3, 4, or 5;

each of ‘a’, ‘d’, ‘g’, ‘i’, ‘l’, and ‘q’ is independently 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10;

each of ‘c’, ‘f’, ‘k’, and ‘p’ is independently 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; and

each of ‘b’, ‘j’, ‘e’, ‘h’, ‘o’, and ‘s’ is independently 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99 or 100.

2. The compound of claim 1 , wherein R 7 is independently —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c NR 10 CONR 11 (CH 2 ) d (CH 2 CH 2 O) e R 20 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c CONR 14 (CH 2 ) d (CH 2 CH 2 O) e R 22 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c NR 15 SO 2 (CH 2 ) d (CH 2 CH 2 O) e R 23 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c SO 2 NR 16 (CH 2 ) d (CH 2 CH 2 O) e R 24 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c NR 17 CO(CH 2 ) d (CH 2 CH 2 O) e R 25 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c NR 18 CO 2 (CH 2 ) d (CH 2 CH 2 O) e R 26 , or —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c OC(O)NR 19 CO 2 (CH 2 ) d (CH 2 CH 2 O) e R 27 .

3. The compound of claim 1 , wherein R 7 is independently —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c NR 10 CONR 11 (CH 2 ) d (CH 2 CH 2 O) e R 20 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c NR 12 CSNR 13 (CH 2 ) d (CH 2 CH 2 O) e R 21 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c CONR 14 (CH 2 ) d (CH 2 CH 2 O) e R 22 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c NR 15 SO 2 (CH 2 ) d (CH 2 CH 2 O) e R 23 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c SO 2 NR 16 (CH 2 ) d (CH 2 CH 2 O) e R 24 , —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c NR 18 CO 2 (CH 2 ) d (CH 2 CH 2 O) e R 26 , or —(CH 2 ) a (CH 2 CH 2 O) b (CH 2 ) c OC(O)NR 19 CO 2 (CH 2 ) d (CH 2 CH 2 O) e R 27 .

4. The compound of claim 1 , wherein:

each of R 20 , R 21 , R 22 , R 23 , R 24 , R 25 , R 26 , and R 27 is independently —H, —CH 3 , —(CH 2 ) f NR 28 C(O)NR 29 (CH 2 ) g (CH 2 CH 2 O) h R 38 , —(CH 2 ) f NR 30 CSNR 31 (CH 2 ) g (CH 2 CH 2 O) h R 39 , —(CH 2 ) f C(O)NR 32 (CH 2 ) g (CH 2 CH 2 O) h R 40 , —(CH 2 ) f S(O) 2 NR 33 (CH 2 ) g (CH 2 CH 2 O) h R 41 , —(CH 2 ) f NR 34 S(O) 2 (CH 2 ) g (CH 2 CH 2 O) h R 42 , —(CH 2 ) f NR 36 C(O)O(CH 2 ) g (CH 2 CH 2 O) h R 44 , —(CH 2 ) f OC(O)NR 37 (CH 2 ) g (CH 2 CH 2 O) h R 45 , —CO(AA), or —CONH(PS).

5. The compound of claim 1 , wherein each of R 31 , R 32 , R 33 , R 34 , R 35 , R 36 , R 37 , R 38 , R 39 , R 40 , R 41 , R 42 , R 43 , R 44 , and R 45 is independently —H or —CH 3 .

6. The compound of claim 1 , wherein:

7. The compound of claim 1 , wherein:

each of ‘a’, ‘d’, ‘g’, ‘i’ and ‘q’ is independently 0, 1, 2, 3, 4, 5, or 6.

8. The compound of claim 1 , wherein:

each of ‘e’, ‘h’, ‘o’, and ‘s’ is independently 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20.

9. The compound of claim 1 , wherein:

each of ‘b’ and ‘j’ is independently 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20.

10. The compound of claim 1 having a molecular weight of no more than 20000.

11. The compound of claim 1 having a molecular weight of no more than 15000, 14000, 13000, 12000, 11000, 10000, 9000, 8000, 7000, 6000, 5000, 4500, 4000, 3500, 3000, 2500, 2000, 1500, 1000, 900, 800, 700, 600, 500, 400, 300, 200, or 100.

12. The compound of claim 1 having a molecular weight that is greater than 20000.

13. The compound of claim 1 wherein each of ‘t’ and ‘u’ is independently 2, 3, 4, or 5.

14. The compound of claim 1 wherein each of ‘t’ and ‘u’ is independently 2.

15. The compound of claim 1 wherein each of ‘a’ is independently 2, 3, 4, or 5.

16. The compound of claim 1 wherein each of ‘a’ is independently 2.

17. A method of using the compound of claim 1 , the method comprising:

administering a compound of claim 1 into a body of a patient;

exposing the compound to visible and/or near infrared light while the compound is in the body of the patient; and

detecting spectral energy emanating from the compound while the compound is in the body of the patient, wherein the compound emanates spectral energy due to the exposing.

18. The method of claim 17 , further comprising determining renal function of the patient based on the detecting.

19. A compound of the following structure:

Assignments (5)

ENTITY CONVERSION Recorded Oct 13, 2015

From: MEDIBEACON, LLC

To: MEDIBEACON, INC.

Reel/Frame 036852/0201 →

CHANGE OF NAME Recorded Feb 7, 2014

From: MEDIBEACON DEVELOPMENT, LLC

To: MEDIBEACON, LLC

Reel/Frame 032169/0485 →

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2012